Effects of Inspiratory Muscle Training and Abdominal Drawing-In Maneuver on Balance, Gait and Pulmonary Function in Stroke Patients
Launched by SAHMYOOK UNIVERSITY · Feb 16, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two specific exercises—Inspiratory Muscle Training (IMT) and the Abdominal Drawing-In Maneuver (ADIM)—can help improve balance, walking, and breathing in people who have had a stroke. The goal is to see if doing these exercises together can help stroke patients move around better and breathe more easily compared to standard rehabilitation methods.
To participate in this study, you need to have had a stroke within the last 1 to 6 months and be able to walk at least 6 meters, even if you need a walking aid. Participants should also have a good level of mental function, as indicated by a Mini-Mental State Examination score of 24 or higher. Unfortunately, some individuals may not be eligible if they have certain health conditions, like severe breathing issues or other neurological disorders. If you join the trial, you can expect to engage in these exercises and receive support to help improve your mobility and respiratory function. This study is currently recruiting participants, so it's a great opportunity to potentially benefit from this innovative approach.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants diagnosed with subacute stroke (1-6 months post-onset)
- • Mini-Mental State Examination-Korean (MMSE-K) score of 24 or higher
- • Ability to walk at least 6 meters, with or without an assistive device
- Exclusion Criteria:
- • Conditions prohibiting the Valsalva maneuver (e.g., glaucoma, aneurysm, pulmonary hypertension)
- • Acute respiratory infections
- • Severe language or cognitive impairments preventing communication
- • Previous inspiratory muscle training within the last 6 months
- • Unstable medical conditions (e.g., uncontrolled hypertension, diabetes)
- • Neurological disorders affecting function and balance (e.g., Parkinson's disease, multiple sclerosis)
- • Severe musculoskeletal impairments limiting functional mobility.
About Sahmyook University
Sahmyook University is a distinguished academic institution based in South Korea, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in health sciences and innovative research methodologies to facilitate high-quality clinical studies. Sahmyook University aims to contribute to the development of effective therapeutic interventions and enhance patient care through rigorous clinical trials that adhere to ethical standards and regulatory guidelines. By fostering collaboration among researchers, healthcare professionals, and industry partners, the university is dedicated to translating scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported